Luo Ying bought GYRE
June 8, 2026 · Form 4 insider transaction
Luo Ying bought 120,000 shares of Gyre Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
120,000
Price
$0.00
Total value
N/A
InsiderLuo Ying
RoleOfficer, Director
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJune 8, 2026
Filing dateJune 10, 2026
Shares owned after120,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option represents a right to purchase a total of 120,000 shares of the Issuer's common stock, 25% of which will vest on June 8, 2027, with the remaining vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer through each vesting date.